Last reviewed · How we verify
NCT06302842: AUXNUTRIMMUN
Pilot Open Label Study With Commercial Supplementation in Healthy Subjects
NA trial testing Bioritmon Immuno Defend in Supportive Care in 15 participants. Completed in 31 December 2024.
15 October 2023
Quick facts
| Lead sponsor | Istituto Auxologico Italiano |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 15 |
| Start date | 1 July 2023 |
| Primary completion | 15 October 2023 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Bioritmon Immuno Defend
Conditions studied
- Supportive Care — all drugs for Supportive Care →
Sponsor
Istituto Auxologico Italiano — full company profile →
Who can join
18 and older, any sex, with Supportive Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A bidirectional relationship among nutrition, infection and immunity exists: changes in one component affect the others. Various micronutrients are essential for immunocompetence, particularly vitamins A, C, D, E, B2, B6, and B12, folic acid, iron, selenium, and zinc. Micronutrient deficiencies are a recognized global public health issue, and poor nutritional status predisposes to certain infections. Immune function may be improved by restoring deficient micronutrients to recommended levels, thereby increasing resistance to infection and supporting faster recovery when infected. Diet alone may be insufficient and tailored micronutrient supplementation based on specific age-related needs is necessary. Aim of the study is to investigate whether nutrient supplementation may affect different functional parameters of the innate and adaptive immunity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06302842
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Supportive Care
Currently open trials in the same condition.
- NCT07505498 — Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set · recruiting
- NCT06604455 — Impact of Acupuncture and Integrative Medicine on Patients Quality-of-life During National Emergency and Wartime · NA · recruiting
- NCT06767826 — The Effect of Care Based on the Salutogenesis Model · NA · active not recruiting
- NCT06237179 — Behavioral Exercise Training to Reduce Cardiovascular Disease Risk · Phase 1, PHASE2 · recruiting
- NCT06663514 — SupporTive Care At Home Research for Patients with Progressive Neurologic Disease Patients (STAHR-Neuro) (HOMECARE) · NA · recruiting
Other Istituto Auxologico Italiano trials
Trials by the same sponsor.
- NCT07384962 — ORION Study: Mesh Position and Risk During Subsequent Minimally Invasive Abdominal Surgery · not yet recruiting
- NCT07358832 — Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease · NA · recruiting
- NCT07302321 — Needs of ALS Patients With C9orf72 Mutation and Their Caregivers · recruiting
- NCT07162740 — Implantable Loop Recorder and Cardioneuroblation · not yet recruiting
- NCT07312240 — LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06302842 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Auxologico Italiano
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06302842.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing